- JNJ +0.45%
Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company
Yahoo Finance · 1 hour ago
Pfizer
Search results
- 147.08Add to watchlist+0.66 (+0.45%)As of Fri. Jun 7, 2024 10:07 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open146.68High147.15Low146.35
- Mkt Cap353.97BP/E (TTM)21.82Div & Yield4.96 & 3.39%
- Prev. Close146.4252 Wk. Low143.1352 Wk. High175.97
What analysts are sayingTop storiesRelated stocks
Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 31, 2024 · Innovating in Health&Care. We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
- www.marketwatch.com
- › …
- › Quotes
- › Stocks
- › United States
2 days ago · JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Explore the Johnson & Johnson Vision Portfolio. Protect, correct, treat and enhance your patients' vision. Contact Lens Products. Ocular Surface Care Products. Surgical Products.
Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life.
Per-Share Earnings, Actuals and Estimates. View the latest Johnson & Johnson (JNJ) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Discover J&J. At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Jan 23, 2024 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2023. “Johnson & Johnson’s full year 2023 results reflect the breadth and competitiveness of our business and our relentless focus on delivering for patients,” said Joaquin Duato, Chairman and Chief Executive Officer.
2 days ago · A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
